BTG Competitors and Similar CompaniesClear all
BTG's competitors and similar companies include Zogenix and Durect.
 Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. | ||
Founding Date | Founding Date 1948 | Founding Date 2006 | Founding Date N/A |
Type | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Emeryville, US HQ Maidenhead, GB | Locations Cupertino, US HQ | |
Employees | Employees 650 | Employees 743% increase | Employees 902% increase |
Financial | |||
Revenue (est.) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $2m (FY, 2024) |
Cost of goods | Cost of goods £221m (FY, 2019) | Cost of goods $4.8m (FY, 2021) | Cost of goods $78k (FY, 2024) |
Gross profit | Gross profit £510.3m (FY, 2019) | Gross profit N/A | Gross profit $2m (FY, 2024) |
Net income | Net income £88.3m (FY, 2019) | Net income ($227.4m) (FY, 2021) | Net income ($8.3m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Zogenix
HQ
Emeryville, US
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View companyDurect
HQ
Cupertino, US
Employees
90↑ 2% increase
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View company